Medium term results of the multimodal injections therapy applied to patients with lumbar radiculopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010257

Enrollment

Registered

2016-04-02

Start date

2010-04-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine problems, lumbar radiculopathy M51.1 M48.06

Interventions

Group 1: This clinical study with a non-randomised unblinded prospective design included male and female patients with lumbar radiculopathy aged 25 to 85 years who had been treated according to a mult

Eligibility

Sex/Gender

All

Age

25 Years to 85 Years

Inclusion criteria

Inclusion criteria: - Radicular low back symptoms with clear symptom leading root -the patient must at least participated in five psychological units -inpatient treatment in accordance to the current guidelines and absolute surgical indications excluded

Exclusion criteria

Exclusion criteria: - Rheumatic and / or inflammatory spinal disorders - Tumors with involvement of the spine and / or congenital spinal deformities - Purely local or purely pseudoradicular lumbar complaints - Clearly psychosomatic disease

Design outcomes

Primary

Measure	Time frame
Pain reduction is evaluated 1 year after therapy with VAS backspin and leg pain	—

Secondary

Measure	Time frame
Improvement of activity (likert scale), BMI and decrease of contact to a doctor 1 year after therapy	—

Countries

Germany

Contacts

Public ContactAchim Benditz

Orthopädische Klinik für die Universität Regensburg

a.benditz@asklepios.com09405184828

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026